Your NEXT Option™
September 20, 2022
NEXT Oncology’s Dr. Anthony Tolcher Presents Data on Well-Tolerated Monotherapy
for Advanced and Metastatic Tumors at ESMO Congress 2022
Latest
See All
September 5, 2022
Sometimes less is more: Reviewing axillary management studies in upfront surgery for patients with early breast cancer stages.
August 19, 2022
Long-term Outcomes of Adjuvant Denosumab in Breast Cancer: Fracture reduction and Survival of 3,425 patients in the randomized, double blind, placebo controlled ABCSG-18 trial.
August 8, 2022
Special Edition: Update on Approval for Immune Therapy in Early-Stage Triple Negative Breast Cancer
July 26, 2022